Express Diagnostics Int’l (EDI) is the FDA-registered, ISO 13485:2016 certified manufacturer of DrugCheck® onsite drugs of abuse screening devices. EDI has grown from five employees to 100 since its founding in 2004 and implementation of in-house manufacturing in 2005.
In recognition of this rapid growth, Inc. magazine recently named EDI to its Inc. 5000 list of fastest-growing companies in the U.S. for the third consecutive year. The company’s combination of toxicology, manufacturing, development, and marketing expertise has helped position Express Diagnostics Int’l as a world leader in rapid drug testing.
Express Diagnostics Global, Ltd. (EDG), a new subsidiary based in Sofia, Bulgaria, is central to a strategic plan to deliver increased production capacity and enhanced support to distributors in the EMEA region (Europe, the Middle East, Africa). Manufacturing at EDG’s Sofia facility is dedicated primarily to satisfying EMEA demand for DrugCheck screening devices.
In addition to the production of rapid drug tests, EDG will offer contract manufacturing and packaging, as well as assistance with research and development, to a wide range of medical products companies.